definiens: shall mean an amount determined on a per locationand per therapeutic class basis that does not exceed 115 % of the Net Revenue compounded annually derived by such locationfor such product for the preceding twelve full consecutive month period . Notwithstanding the foregoing, to the extent aninfusion patient is converted to a patient who is treated with any injectable product subject to the first paragraph ofSection 4.04(d ) ( the ), any Net Revenue derived from such Converted Patients shall be applied towardsthe 115 % limit in the previous sentence and any Net Revenue derived from any Converted Patients shall be added to NetRevenue for the preceding twelve ( 12 ) month period on a pro forma basis . For locations controlled by any [COMPANY] Entity asof the Closing Date, the measurement period shall be the twelve ( 12 ) full month period immediately preceding the ClosingDate and each twelve ( 12 ) full month period thereafter prior to the fifth anniversary of the Closing Date . For locationsacquired by any [COMPANY] Entity that do not constitute Prohibited Acquired Business, the measurement period shall be thetwelve ( 12 ) full month period immediately preceding the date of acquisition of such location by any [COMPANY] Entity and eachtwelve ( 12 ) full month period thereafter prior to the fifth anniversary of the Closing Date . If any [COMPANY] Entity acquiresoperations to be consolidated with other [COMPANY] locations, the DeMinimis Sales Levels shall be calculated on a pro formabasis based on combined sales for the referenced time period